The News Prohost Was Waiting for to Post Its Special Letter
Prohost has one eye on the development-stage biotech and biopharmaceutical companies' scientific fundamentals and accomplishments as well as the financial results on the revenue-generating firms. Prohost has the second eye on the market performance, its volatility and the possible reasons it sinks every other day, or every other week, in calmer days during a solid economy.

Most of the firms that Prohost has picked, and installed in its portfolio, reported encouraging,excellent news about their accomplishments with . . .